Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset | Zendy

Josée Perreault | Zendy; Tony Tremblay | Zendy; Marie-Josée Fournier | Zendy; Mathieu Drouin | Zendy; Guillaume Beaudoin-Bussières | Zendy; Jérémie Prévost | Zendy; Antoine Lewin | Zendy; Philippe Bégin | Zendy; Andrés Finzi | Zendy; Renée Bazin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset

Author(s) -

Josée Perreault,

Tony Tremblay,

Marie-Josée Fournier,

Mathieu Drouin,

Guillaume Beaudoin-Bussières,

Jérémie Prévost,

Antoine Lewin,

Philippe Bégin,

Andrés Finzi,

Renée Bazin

Publication year - 2020

Publication title -

blood

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.515

H-Index - 465

eISSN - 1528-0020

pISSN - 0006-4971

DOI - 10.1182/blood.2020008367

Subject(s) - convalescent plasma , antibody , seroprevalence , virology , titer , covid-19 , medicine , antibody titer , immunology , neutralizing antibody , serology , disease , outbreak , infectious disease (medical specialty)

Perreault and colleagues examined antibody titers in sequential samples from serum donors recovering from COVID-19 and demonstrated that antibody titers fall over 3-4 months. These results have important implications for convalescent serum collection and seroprevalence studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research